MedTrace Logo

Effects of Inpatient Rehabilitation Measures in Long-COVID-19 Syndrome

NCT05599906 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-03-29

No results posted yet for this study

Summary

The aim of the present study is to answer the question of whether a rehabilitation measure has a positive effect on fatigue symptoms, physical performance, and the physical and psychological well-being of the patients. In particular, the fatigue that occurs in most of all patients is of interest here. In order to make this measurable, the FAS questionnaire plays a special role, which should be completed by all 100 patients upon inclusion in the study and upon discharge from the rehabilitation clinic. In addition, the HADS-D questionnaire (Hospital Anxiety and Depression Scale) for self-assessment of depressive symptoms and anxiety symptoms and the SF-12 questionnaire (Short Form Health Survey) are used as a screening tool to assess health-related quality of life.

For the clinical examination of physical performance, the six-minute walk test, a body plethysmography and a long-term ECG are performed on recruited patients on admission and before discharge. In a three-month follow-up, all recruited patients should receive an FAS, HADS-D and SF-12 questionnaire to fill out. Some of these will also be called back to the clinic to check the development of lung function or performance, defined on the basis of VO2max, and will undergo an additional spiroergometric examination.

Thus, the effectiveness and effectiveness of the rehabilitation measures in patients under long-COVID is checked.

Conditions

Interventions

OTHER

questionnaires

Completion of 3 questionnaires (HADS; SF-12; FAS) at the beginning and end of the rehabilitation and after 3 months

Sponsors & Collaborators

  • Paracelsus Harz Clinic Bad Suderode.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2023-05-31
Completion
2023-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05599906 on ClinicalTrials.gov